Peter is a corporate financier with over 30 years’ experience in corporate finance and venture capital. He has acted on and assisted a wide range of companies to attain a listing over many years on the Unlisted Securities Market, the Main Market of the London Stock Exchange and AIM, whether by IPO or in many cases via reverse takeovers, across a wide range of sectors, ranging from technology through financial services to natural resources and, in recent years has done so as a director of the companies concerned. He was a founder director of Cleeve Capital plc (now Satellite Solutions Worldwide Group plc) and Mithril Capital plc (now Be Heard Group plc), both listed on AIM, and took a leading role in the reconstruction and refinancing of AIM-quoted 3Legs Resources plc (now SalvaRx). Peter was also primarily responsible for the decision for the Company to invest in both SalvaRx and Eco. He is also a director of Hemogenyx plc (where he was involved in creating the precursor vehicle) and URA Holdings plc.
This person is not in the org chart
This person is not in any teams